Evidence map›Paper›PMID 26512646›Full record

ReviewInternational journal of molecular sciences2015

Diabetic Cardiovascular Disease Induced by Oxidative Stress.

Yosuke Kayama, Uwe Raaz, Ann Jagger, Matti Adam, Isabel N Schellinger, Masaya Sakamoto, Hirofumi Suzuki, Kensuke Toyama, Joshua M Spin, Philip S Tsao

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 171 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
171citing papers in PubMed, 3 pooled it
28.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

171 citing papers in PubMed, 3 syntheses or guidelines pooled it, 406 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Vascular Function and Uric Acid-Lowering in Stage 3 CKD.Journal of the American Society of Nephrology : JASN · 2017
    Trial
  6. Article
  7. Review
  8. Review
  9. Article
  10. Antioxidant and Anticoagulant Screening ofCardiovascular & hematological disorders drug targets · 2026
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Multitargeted Effects ofInternational journal of molecular sciences · 2025
    Article
  20. Article

111 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Yosuke KayamaDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA. kayama@jikei.ac.jp.
Uwe RaazDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA. uwe.raaz@googlemail.com.
Ann JaggerDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA. jagger.ann@gmail.com.
Matti AdamDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA. matti.adam@uk-koeln.de.
Isabel N SchellingerDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA. isabelschellinger@googlemail.com.
Masaya SakamotoDivision of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minatoku, Tokyo 105-0003, Japan. m-sakamoto@umin.ac.jp.
Hirofumi SuzukiDivision of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minatoku, Tokyo 105-0003, Japan. hiro1020@jikei.ac.jp.
Kensuke ToyamaDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA. ktoyama@stanford.edu.
Joshua M SpinDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA. josh.spin@gmail.com.
Philip S TsaoDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA. ptsao@stanford.edu.
Stanford University · USVA Palo Alto Health Care System · USJikei University School of Medicine · JP

Funding

Insulin Resistance, Vascular Stiffness, and HypertensionR01HL105299 · NHLBI · STANFORD UNIVERSITY · PI TSAO, PHILIP S · 2010 to 2013
$1.6M
MicroRNA Regulation of Nicotine Accelerated AAAsR01HL122939 · NHLBI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI TSAO, PHILIP S · 2014 to 2017
$1.4M
Regulatory Role of MicroRNAs in Aging-related Abdominal Aortic Aneurysm DiseaseI01BX002641 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI TSAO, PHILIP S · 2015 to 2019
–
BLRD VA I01 BX002641NHLBI NIH HHS 1R011HL122939NHLBI NIH HHS 1R01HL105299NHLBI NIH HHS R01 HL105299NHLBI NIH HHS R01 HL122939
6 · The paper itself

Abstract

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among patients with diabetes mellitus (DM). DM can lead to multiple cardiovascular complications, including coronary artery disease (CAD), cardiac hypertrophy, and heart failure (HF). HF represents one of the most common causes of death in patients with DM and results from DM-induced CAD and diabetic cardiomyopathy. Oxidative stress is closely associated with the pathogenesis of DM and results from overproduction of reactive oxygen species (ROS). ROS overproduction is associated with hyperglycemia and metabolic disorders, such as impaired antioxidant function in conjunction with impaired antioxidant activity. Long-term exposure to oxidative stress in DM induces chronic inflammation and fibrosis in a range of tissues, leading to formation and progression of disease states in these tissues. Indeed, markers for oxidative stress are overexpressed in patients with DM, suggesting that increased ROS may be primarily responsible for the development of diabetic complications. Therefore, an understanding of the pathophysiological mechanisms mediated by oxidative stress is crucial to the prevention and treatment of diabetes-induced CVD. The current review focuses on the relationship between diabetes-induced CVD and oxidative stress, while highlighting the latest insights into this relationship from findings on diabetic heart and vascular disease.

Indexed as

Oxidative StressAnimalsDiabetic CardiomyopathiesFibrosisHumanscardiovascular diseasediabetes mellitusdiabetic heartdiabetic vascular diseaseoxidative stress

Identifiers

PMID26512646
PMCPMC4632800
OpenAlexW2166057024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.